默瑞生物是美国MTI-globalstem总代理73761-DNA-In® HepG2 /现货
默瑞生物是美国MTI-globalstem公司的中国授权总代理商，欢迎大家咨询订货。
默瑞热线：4006-400-850
售前咨询：info@moreybio.com
产品订购：order@moreybio.com
售后支持：tech@moreybio.com
默瑞官网：www.moreybio.com
产品介绍：
产品名称：DNA-In® HepG2
产品描述：
| Information | |
| Cell Type | Formulated specifcally for HepG2 cells |
| Classification | Defined, animal origin-free |
| Size | 0.1 ml, 1 ml, 5x1 ml and 10x1 ml |
| Sample Type | Plasmid DNA |
| Serum Compatibility | Yes |
| Shipping | Ships at room temperature; Store at 4°C ; DO NOT FREEZE |
| Other | FOR RESEARCH USE ONLY - Not intended for any animal or human therapeutic or diagnostic use. |
DNA-In® HepG2
Formulated Specifically for HepG2 Cells
DNA-In® Cell-Specific Transfection Reagents are a line of transfection products developed by the lead members of the scientific team that invented the Lipofectamine® and Lipofectamine® 2000. These cell-specific reagents offer maximum DNA delivery in targeted common cell lines.
DNA-In® HepG2 Transfection Reagent provides maximum transfection efficiency, gene expression levels and cell viability in HepG2 cells, a human epithelial, hepatocellular carcinoma cell line, commonly used as a model to study of human liver diseases, including investigation of liver metabolism and toxicity.
Product sheet
Features
Fast, simple, easy-to-follow protocol
One-step process: simply add DNA-In® HepG2 Transfection Reagent to diluted DNA, incubate 10 minutes, and add to pre-plated cells
Minimal toxicity - no need to replace medium after transfection
DNA-In® HepG2 Transfection Reagent Quick-Start Protocol
DNA-In® HepG2 Transfection Reagent provides Maximum Transfection Efficiency in HepG2 cells
Above, HepG2 cells were plated at 70% - 80% confluency. They were subsequently transfected with the EF-1 alpha promoter-GFP 24 hours after plating. Significantly higher efficiency was consistently observed in HepG2 cells transfected with DNA-In® HepG2 Reagent (left image) vs LF3K (right image) transfected cells.
公司介绍
mti-globalstem，是生命科学领域前沿工具和试剂的供应商。mti-globalstem提供优势产品在转染试剂、神经科学、干细胞生物学。他们填补了原代和ipsc获得神经细胞、干细胞和饲养层细胞的空白，优化了生长培养基和补充物质，提供了一个贵族试剂的创新平台——最大效率的递送核酸到干细胞和神经细胞。
MTI-GlobalStem公司成立于2006年，最初名为GlobalStem，在2010年被Molecular Transfer公司(MTI)收购，总部位于美国马里兰州盖瑟斯堡，致力于开发和推广细胞转染、神经生物学以及干细胞研究所用的工具和试剂。此外，这家公司还提供干细胞、分化神经元和大规模的细胞培养制造服务。
默瑞生物是美国MTI-globalstem公司, 73761-DNA-In® HepG2 /现货/代理商
